To diagnose Melanoma, a type of skin cancer which is less familiar but extremely treacherous has never been so easy for the physicians. But now a team of analysts has developed a new technology which can easily diagnose Melanoma and also can help the physicians to detect it at its premature stages. People suffering from Melanoma skin cancer usually have spy-looking developments on their skin which is likely to be asymmetrical in shape, size, and color. The symptoms of this disease are closely related to the signs of the benign ones, and this makes it difficult to detect. But, with the employment of the new automated technology, this type of skin cancer can easily be diagnosed and detected at its early stage.
A group of researchers from Rockefeller University has invented computerized machinery that can help physicians become aware of malignancy at its early stages. The early recognition of Melanoma plays a pivotal role in lessening the mortality rate from sarcoma and the new technology can help the doctors to do so. The new method can enhance the diagnosis process of melanoma as well as can also potentially replace the method of screening which currently used as a standard method for identifying the skin cancer.
The new approach of diagnosing Melanoma includes computer algorithms that monitor and calculate the images of injuries and give attention to quantitative information from the pictures including shape and shade of sores. After this, the system will generate a general danger score that is known as a Q-score, demonstrating the possibilities of creating melanoma skin growth. A score between around zero and one speaks to the higher potentiality of injury being a cancerous tumor.
On this matter, the co-author of the study, Mr. James Krueger said, “The real need for standardization of the growth of Melanoma across the field of dermatology is extremely essential. Diagnosis of this disease by means of screening does save our lives but, visually, it is very tough and challenging. Moreover, when a doubtful lesion is removed and biopsied, the confirmation of it to be melanoma is only 10%.”
On this matter, the Lead author of the study Daniel Gareau who is also working as an instructor in clinical investigation in the Krueger laboratory claimed that the new approach will make the detection of Melanoma in its premature state possible with 98% accuracy. However, the 100% successful detection of this type of skin cancer will be marked by the complete development of the technology.
The study published in the academic journal of “Experimental Dermatology”. The study was endorsed and supported mutually by the National Institutes of Health, Paul and Irma Milstein Family Foundation and the American Skin Association.